4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-12-001898
Options or other derivatives
- Director acquired 45,651 shares (grant or award)
- Director returned 67,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Lockshin Curtis · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-12-21 | Returned to the company : show line 1 in the form Employee Stock Options (right to buy) | −67,500 | $1.54 | 2021-05-10 | 67,500 | 67,500 | D |
| 2012-12-21 | Grant or award : show line 2 in the form Employee Stock Options (right to buy) | +45,651 | $0.95 | 2022-09-15 | 45,651 | 113,151 | D |
Loading xslF345X03/form4-12262012_071259.xml…